{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:54:28Z","timestamp":1787918068952,"version":"build-2784847793"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["SEP-CONACYT 237864"],"award-info":[{"award-number":["SEP-CONACYT 237864"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["SEP-CONACYT 220990"],"award-info":[{"award-number":["SEP-CONACYT 220990"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12964-018-0257-7","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T08:09:08Z","timestamp":1534234148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Kv1.3 channel blockade with the Vm24 scorpion toxin attenuates the CD4+ effector memory T cell response to TCR stimulation"],"prefix":"10.1186","volume":"16","author":[{"given":"Jos\u00e9 Ignacio","family":"Veytia-Bucheli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana Mar\u00eda","family":"Jim\u00e9nez-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Isabel","family":"Melchy-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monserrat Alba","family":"Sandoval-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourival Domingos","family":"Possani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4040-4256","authenticated-orcid":false,"given":"Yvonne","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"257_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-immunol-032414-112212","volume":"33","author":"S Feske","year":"2015","unstructured":"Feske S, Wulff H, Skolnik EY. Ion channels in innate and adaptive immunity. Annu Rev Immunol. 2015;33:291\u2013353.","journal-title":"Annu Rev Immunol"},{"key":"257_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1600-065X.2009.00816.x","volume":"231","author":"MD Cahalan","year":"2009","unstructured":"Cahalan MD, Chandy KG. The functional network of ion channels in T lymphocytes. Immunol Rev. 2009;231:59\u201387.","journal-title":"Immunol Rev"},{"key":"257_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nri2152","volume":"7","author":"S Feske","year":"2007","unstructured":"Feske S. Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol. 2007;7:690\u2013702.","journal-title":"Nat Rev Immunol."},{"key":"257_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tips.2004.03.010","volume":"25","author":"K George Chandy","year":"2004","unstructured":"George Chandy K, Wulff H, Beeton C, Pennington M, Gutman GA, Cahalan MD. K+ channels as targets for specific immunomodulation. Trends Pharmacol Sci. 2004;25:280\u20139.","journal-title":"Trends Pharmacol Sci"},{"key":"257_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1124\/pr.57.4.10","volume":"57","author":"GA Gutman","year":"2005","unstructured":"Gutman GA. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev. 2005;57:473\u2013508.","journal-title":"Pharmacol Rev"},{"key":"257_CR6","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1172\/JCI16921","volume":"111","author":"H Wulff","year":"2003","unstructured":"Wulff H, Calabresi PA, Allie R, Yun S, Pennington M, Beeton C, et al. The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS. J Clin Invest. 2003;111:1703\u201313.","journal-title":"J Clin Invest"},{"key":"257_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, F\u00f6rster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708\u201312.","journal-title":"Nature"},{"key":"257_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","volume":"22","author":"F Sallusto","year":"2004","unstructured":"Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745\u201363.","journal-title":"Annu Rev Immunol"},{"key":"257_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/35065111","volume":"410","author":"RL Reinhardt","year":"2001","unstructured":"Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the generation of memory CD4 T cells in the whole body. Nature. 2001;410:101\u20135.","journal-title":"Nature"},{"key":"257_CR10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","volume":"41","author":"JM Schenkel","year":"2014","unstructured":"Schenkel JM, Masopust D. Tissue-resident memory T cells. Immunity. 2014;41:886\u201397.","journal-title":"Immunity"},{"key":"257_CR11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","volume":"45","author":"C Gerlach","year":"2016","unstructured":"Gerlach C, Moseman EA, Loughhead SM, Alvarez D, Zwijnenburg AJ, Waanders L, et al. The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis. Immunity. 2016;45:1270\u201384.","journal-title":"Immunity"},{"key":"257_CR12","doi-asserted-by":"publisher","first-page":"936","DOI":"10.4049\/jimmunol.166.2.936","volume":"166","author":"C Beeton","year":"2001","unstructured":"Beeton C, Barbaria J, Giraud P, Devaux J, Benoliel A-M, Gola M, et al. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J Immunol. 2001;166:936\u201344.","journal-title":"J Immunol"},{"key":"257_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1124\/jpet.112.191890","volume":"342","author":"EJ Tarcha","year":"2012","unstructured":"Tarcha EJ, Chi V, Munoz-Elias EJ, Bailey D, Londono LM, Upadhyay SK, et al. Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease. J Pharmacol Exp Ther. 2012;342:642\u201353.","journal-title":"J Pharmacol Exp Ther"},{"key":"257_CR14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1124\/mol.104.008193","volume":"67","author":"C Beeton","year":"2005","unstructured":"Beeton C. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol. 2005;67:1369\u201381.","journal-title":"Mol Pharmacol"},{"key":"257_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.immuni.2008.07.015","volume":"29","author":"MP Matheu","year":"2008","unstructured":"Matheu MP, Beeton C, Garcia A, Chi V, Rangaraju S, Safrina O, et al. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity. 2008;29:602\u201314.","journal-title":"Immunity"},{"key":"257_CR16","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0605136103","volume":"103","author":"C Beeton","year":"2006","unstructured":"Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci. 2006;103:17414\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"257_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.toxicon.2013.07.012","volume":"76","author":"V Quintero-Hern\u00e1ndez","year":"2013","unstructured":"Quintero-Hern\u00e1ndez V, Jim\u00e9nez-Vargas JM, Gurrola GB, Valdivia HH, Possani LD. Scorpion venom components that affect ion-channels function. Toxicon. 2013;76:328\u201342.","journal-title":"Toxicon"},{"key":"257_CR18","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.4049\/jimmunol.179.7.4563","volume":"179","author":"L Hu","year":"2007","unstructured":"Hu L, Pennington M, Jiang Q, Whartenby KA, Calabresi PA. Characterization of the Functional Properties of the Voltage-Gated Potassium Channel Kv1.3 in Human CD4+ T Lymphocytes. J Immunol. 2007;179:4563\u201370.","journal-title":"J Immunol"},{"key":"257_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/296090a0","volume":"296","author":"E Carbone","year":"1982","unstructured":"Carbone E, Wanke E, Prestipino G, Possani LD, Maelicke A. Selective blockage of voltage-dependent K+ channels by a novel scorpion toxin. Nature. 1982;296:90\u20131.","journal-title":"Nature"},{"key":"257_CR20","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1096\/fj.14-251967","volume":"28","author":"S Chhabra","year":"2014","unstructured":"Chhabra S, Chang SC, Nguyen HM, Huq R, Tanner MR, Londono LM, et al. Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases. FASEB J. 2014;28:3952\u201364.","journal-title":"FASEB J"},{"key":"257_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.toxicon.2011.07.016","volume":"59","author":"V Chi","year":"2012","unstructured":"Chi V, Pennington MW, Norton RS, Tarcha EJ, Londono LM, Sims-Fahey B, et al. Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. Toxicon. 2012;59:529\u201346.","journal-title":"Toxicon"},{"key":"257_CR22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0026-895X(25)10594-4","volume":"45","author":"S Grissmer","year":"1994","unstructured":"Grissmer S, Nguyen AN, Aiyar J, Hanson DC, Mather RJ, Gutman GA, et al. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol. 1994;45:1227\u201334.","journal-title":"Mol Pharmacol"},{"key":"257_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1124\/mol.112.078006","volume":"82","author":"Z Varga","year":"2012","unstructured":"Varga Z, Gurrola-Briones G, Papp F, de la Vega RC R, Pedraza-Alva G, Tajhya RB, et al. Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells. Mol Pharmacol. 2012;82:372\u201382.","journal-title":"Mol Pharmacol"},{"key":"257_CR24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nrd2983","volume":"8","author":"H Wulff","year":"2009","unstructured":"Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov. 2009;8:982\u20131001.","journal-title":"Nat Rev Drug Discov"},{"key":"257_CR25","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1021\/bi300060n","volume":"51","author":"GB Gurrola","year":"2012","unstructured":"Gurrola GB, Hern\u00e1ndez-L\u00f3pez RA, de la Vega RC R, Varga Z, CVF B, Salas-Castillo SP, et al. Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes. Biochemistry. 2012;51:4049\u201361.","journal-title":"Biochemistry"},{"key":"257_CR26","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1002\/pmic.201200152","volume":"12","author":"BJ Barkla","year":"2012","unstructured":"Barkla BJ, Vera-Estrella R, Pantoja O. Protein profiling of epidermal bladder cells from the halophyte Mesembryanthemum crystallinum. Proteomics. 2012;12:2862\u20135.","journal-title":"Proteomics"},{"key":"257_CR27","doi-asserted-by":"publisher","first-page":"10359","DOI":"10.1128\/JVI.01225-15","volume":"89","author":"A Murillo","year":"2015","unstructured":"Murillo A, Vera-Estrella R, Barkla BJ, M\u00e9ndez E, Arias CF. Identification of host cell factors associated with Astrovirus replication in Caco-2 cells. J Virol. 2015;89:10359\u201370.","journal-title":"J Virol"},{"key":"257_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1385\/1-59745-026-X:217","volume-title":"New and emerging proteomic techniques","author":"RC Beavis","year":"2006","unstructured":"Beavis RC. Using the global proteome machine for protein identification. In: Nedelkov D, Nelson RW, editors. New and emerging proteomic techniques. New Jersey: Humana Press; 2006. p. 217\u201328."},{"key":"257_CR29","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1021\/ac025747h","volume":"74","author":"A Keller","year":"2002","unstructured":"Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search. Anal Chem. 2002;74:5383\u201392.","journal-title":"Anal Chem"},{"key":"257_CR30","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1021\/ac0341261","volume":"75","author":"AI Nesvizhskii","year":"2003","unstructured":"Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem. 2003;75:4646\u201358.","journal-title":"Anal Chem"},{"key":"257_CR31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1074\/mcp.M500061-MCP200","volume":"4","author":"Y Ishihama","year":"2005","unstructured":"Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics. 2005;4:1265\u201372.","journal-title":"Mol Cell Proteomics"},{"key":"257_CR32","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein\u2013protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447\u201352.","journal-title":"Nucleic Acids Res"},{"key":"257_CR33","doi-asserted-by":"crossref","unstructured":"Howe E, Holton K, Nair S, Schlauch D, Sinha R, Quackenbush J. Biomedical Informatics for Cancer Research. In: Ochs MF, Casagrande JT, Davuluri R V., editors. Biomedical Informatics for Cancer Research. Boston, MA: Springer US; 2010. p. 267\u2013277.","DOI":"10.1007\/978-1-4419-5714-6_15"},{"key":"257_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1479-5876-8-104","volume":"8","author":"Y Li","year":"2010","unstructured":"Li Y, Kurlander RJ. Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation. J Transl Med. 2010;8:104.","journal-title":"J Transl Med"},{"key":"257_CR35","doi-asserted-by":"publisher","first-page":"14644","DOI":"10.1038\/ncomms14644","volume":"8","author":"EY Chiang","year":"2017","unstructured":"Chiang EY, Li T, Jeet S, Peng I, Zhang J, Lee WP, et al. Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions. Nat Commun. 2017;8:14644.","journal-title":"Nat Commun"},{"key":"257_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri3567","volume":"14","author":"DL Farber","year":"2014","unstructured":"Farber DL, Yudanin NA, Restifo NP. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol. 2014;14:24\u201335.","journal-title":"Nat Rev Immunol."},{"key":"257_CR37","doi-asserted-by":"publisher","first-page":"7948","DOI":"10.4049\/jimmunol.180.12.7948","volume":"180","author":"H Liu","year":"2008","unstructured":"Liu H, Rohowsky-Kochan C. Regulation of IL-17 in human CCR6+ effector memory T cells. J Immunol. 2008;180:7948\u201357.","journal-title":"J Immunol"},{"key":"257_CR38","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.immuni.2017.02.010","volume":"46","author":"H Tan","year":"2017","unstructured":"Tan H, Yang K, Li Y, Shaw TI, Wang Y, Blanco DB, et al. Integrative proteomics and Phosphoproteomics profiling reveals dynamic signaling networks and bioenergetics pathways underlying T cell activation. Immunity. 2017;46:488\u2013503.","journal-title":"Immunity"},{"key":"257_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cmet.2016.06.007","volume":"24","author":"N Ron-Harel","year":"2016","unstructured":"Ron-Harel N, Santos D, Ghergurovich JM, Sage PT, Reddy A, Lovitch SB, et al. Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation. Cell Metab. 2016;24:104\u201317.","journal-title":"Cell Metab"},{"key":"257_CR40","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/eji.201344279","volume":"44","author":"M Huber","year":"2014","unstructured":"Huber M, Lohoff M. IRF4 at the crossroads of effector T-cell fate decision. Eur J Immunol. 2014;44:1886\u201395.","journal-title":"Eur J Immunol"},{"key":"257_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cardiores.2005.10.009","volume":"69","author":"AA Knowlton","year":"2006","unstructured":"Knowlton AA. NF\u03baB, heat shock proteins, HSF-1, and inflammation. Cardiovasc Res. 2006;69:7\u20138.","journal-title":"Cardiovasc Res"},{"key":"257_CR42","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/eji.1830210707","volume":"21","author":"C Boyer","year":"1991","unstructured":"Boyer C, Auphan N, Luton F, Malburet J-M, Barad M, Bizozzero J-P, et al. T cell receptor\/CD3 complex internalization following activation of a cytolytic T cell clone: evidence for a protein kinase C-independent staurosporine-sensitive step. Eur J Immunol. 1991;21:1623\u201334.","journal-title":"Eur J Immunol"},{"key":"257_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1074-7613(00)80169-7","volume":"12","author":"ES Jos\u00e9","year":"2000","unstructured":"Jos\u00e9 ES, Borroto A, Niedergang F, Alcover A, Alarc\u00f3n B. Triggering the TCR complex causes the Downregulation of nonengaged receptors by a signal transduction-dependent mechanism. Immunity. 2000;12:161\u201370.","journal-title":"Immunity"},{"key":"257_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2014.07.003","volume":"55","author":"S Kundu-Raychaudhuri","year":"2014","unstructured":"Kundu-Raychaudhuri S, Chen Y-J, Wulff H, Raychaudhuri SP. Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis \u2013 Xenograft model. J Autoimmun. 2014;55:63\u201372.","journal-title":"J Autoimmun"},{"key":"257_CR45","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1084\/jem.188.7.1369","volume":"188","author":"K Schuh","year":"1998","unstructured":"Schuh K, Twardzik T, Kneitz B, Heyer J, Schimpl A, Serfling E. The interleukin 2 receptor \u03b1 chain\/CD25 promoter is a target for nuclear factor of activated T cells. J Exp Med. 1998;188:1369\u201373.","journal-title":"J Exp Med"},{"key":"257_CR46","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1074\/jbc.271.7.3763","volume":"271","author":"AV Tsytsykova","year":"1996","unstructured":"Tsytsykova AV, Tsitsikov EN, Geha RS. The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J Biol Chem. 1996;271:3763\u201370.","journal-title":"J Biol Chem"},{"key":"257_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jaci.2010.05.010","volume":"126","author":"P Mart\u00edn","year":"2010","unstructured":"Mart\u00edn P, G\u00f3mez M, Lamana A, Mar\u00edn AM, Cort\u00e9s JR, Ram\u00edrez-Huesca M, et al. The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity. J Allergy Clin Immunol. 2010;126:355\u201365.e3.","journal-title":"J Allergy Clin Immunol"},{"key":"257_CR48","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.it.2004.12.006","volume":"26","author":"D Sancho","year":"2005","unstructured":"Sancho D, G\u00f3mez M, S\u00e1nchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 2005;26:136\u201340.","journal-title":"Trends Immunol"},{"key":"257_CR49","doi-asserted-by":"publisher","first-page":"30412","DOI":"10.1074\/jbc.272.48.30412","volume":"272","author":"A Sica","year":"1997","unstructured":"Sica A, Dorman L, Viggiano V, Cippitelli M, Ghosh P, Rice N, et al. Interaction of NF-\u03baB and NFAT with the interferon-\u03b3 promoter. J Biol Chem. 1997;272:30412\u201320.","journal-title":"J Biol Chem"},{"key":"257_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4049\/jimmunol.180.1.319","volume":"180","author":"O Kaminuma","year":"2008","unstructured":"Kaminuma O, Kitamura F, Kitamura N, Hiroi T, Miyoshi H, Miyawaki A, et al. Differential contribution of NFATc2 and NFATc1 to TNF- gene expression in T cells. J Immunol. 2008;180:319\u201326.","journal-title":"J Immunol"},{"key":"257_CR51","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1084\/jem.178.4.1365","volume":"178","author":"AE Goldfeld","year":"1993","unstructured":"Goldfeld AE. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J Exp Med. 1993;178:1365\u201379.","journal-title":"J Exp Med"},{"key":"257_CR52","doi-asserted-by":"crossref","first-page":"30445","DOI":"10.1016\/S0021-9258(18)43833-1","volume":"269","author":"PG McCaffrey","year":"1994","unstructured":"McCaffrey PG, Goldfeld AE, Rao A. The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-\u03b1 gene transcription. J Biol Chem. 1994;269:30445\u201350.","journal-title":"J Biol Chem"},{"key":"257_CR53","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1128\/MCB.13.8.4793","volume":"13","author":"SJ Szabo","year":"1993","unstructured":"Szabo SJ, Gold JS, Murphy TL, Murphy KM. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol Cell Biol. 1993;13:4793\u2013805.","journal-title":"Mol Cell Biol"},{"key":"257_CR54","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.1093\/nar\/21.24.5694","volume":"21","author":"S Chuvpilo","year":"1993","unstructured":"Chuvpilo S, Schomberg C, Gerwig R, Heinfling A, Reeves R, Grummt F, et al. Multiple closely-linked NFAT\/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res. 1993;21:5694\u2013704.","journal-title":"Nucleic Acids Res"},{"key":"257_CR55","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/j.1460-2075.1994.tb06300.x","volume":"13","author":"JW Rooney","year":"1994","unstructured":"Rooney JW, Hodge MR, McCaffrey PG, Rao A, Glimcher LH. A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J. 1994;13:625\u201333.","journal-title":"EMBO J"},{"key":"257_CR56","doi-asserted-by":"publisher","first-page":"16453","DOI":"10.1074\/jbc.272.26.16453","volume":"272","author":"KS Stranick","year":"1997","unstructured":"Stranick KS, Zambas DN, Uss AS, Egan RW, Billah MM, Umland SP. Identification of transcription factor binding sites important in the regulation of the human Interleukin-5 gene. J Biol Chem. 1997;272:16453\u201365.","journal-title":"J Biol Chem"},{"key":"257_CR57","doi-asserted-by":"publisher","first-page":"17541","DOI":"10.1074\/jbc.270.29.17541","volume":"270","author":"HJ Lee","year":"1995","unstructured":"Lee HJ, Masuda ES, Arai N, Arai K, Yokota T. Definition of cis -regulatory elements of the mouse Interleukin-5 gene promoter. J Biol Chem. 1995;270:17541\u201350.","journal-title":"J Biol Chem"},{"key":"257_CR58","doi-asserted-by":"publisher","first-page":"15445","DOI":"10.1074\/jbc.M112.340356","volume":"287","author":"A Jash","year":"2012","unstructured":"Jash A, Sahoo A, Kim G-C, Chae C-S, Hwang J-S, Kim J-E, et al. Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-\u03baB (NF-\u03baB)-mediated Interleukin-9 (IL-9) transactivation. J Biol Chem. 2012;287:15445\u201357.","journal-title":"J Biol Chem"},{"key":"257_CR59","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1093\/emboj\/19.17.4783","volume":"19","author":"F Macian","year":"2000","unstructured":"Macian F. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J. 2000;19:4783\u201395.","journal-title":"EMBO J"},{"key":"257_CR60","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.4049\/jimmunol.1103095","volume":"188","author":"AR Gocke","year":"2012","unstructured":"Gocke AR, Lebson LA, Grishkan IV, Hu L, Nguyen HM, Whartenby KA, et al. Kv1.3 deletion biases T cells toward an Immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis. J Immunol. 2012;188:5877\u201386.","journal-title":"J Immunol"},{"key":"257_CR61","doi-asserted-by":"publisher","first-page":"12623","DOI":"10.1074\/jbc.M113.517037","volume":"289","author":"S Koshy","year":"2014","unstructured":"Koshy S, Huq R, Tanner MR, Atik MA, Porter PC, Khan FS, et al. Blocking Kv 1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma. J Biol Chem. 2014;289:12623\u201332.","journal-title":"J Biol Chem"},{"key":"257_CR62","doi-asserted-by":"publisher","first-page":"46818","DOI":"10.1074\/jbc.M401722200","volume":"279","author":"S-H Im","year":"2004","unstructured":"Im S-H, Hueber A, Monticelli S, Kang K-H, Rao A. Chromatin-level regulation of the IL10 gene in T cells. J Biol Chem. 2004;279:46818\u201325.","journal-title":"J Biol Chem"},{"key":"257_CR63","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.molimm.2008.07.037","volume":"46","author":"C-G Lee","year":"2009","unstructured":"Lee C-G, Kang K-H, So J-S, Kwon H-K, Son J-S, Song M-K, et al. A distal cis-regulatory element, CNS-9, controls NFAT1 and IRF4-mediated IL-10 gene activation in T helper cells. Mol Immunol. 2009;46:613\u201321.","journal-title":"Mol Immunol"},{"key":"257_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1189\/jlb.0612293","volume":"93","author":"I Shachar","year":"2013","unstructured":"Shachar I, Karin N. The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications. J Leukoc Biol. 2013;93:51\u201361.","journal-title":"J Leukoc Biol"},{"key":"257_CR65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.0105-2896.2009.00864.x","volume":"233","author":"PS Biswas","year":"2010","unstructured":"Biswas PS, Bhagat G, Pernis AB. IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? Immunol Rev. 2010;233:79\u201396.","journal-title":"Immunol Rev"},{"key":"257_CR66","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1073\/pnas.1309378110","volume":"110","author":"F Raczkowski","year":"2013","unstructured":"Raczkowski F, Ritter J, Heesch K, Schumacher V, Guralnik A, Hocker L, et al. The transcription factor interferon regulatory factor 4 is required for the generation of protective effector CD8+ T cells. Proc Natl Acad Sci. 2013;110:15019\u201324.","journal-title":"Proc Natl Acad Sci"},{"key":"257_CR67","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.immuni.2010.07.014","volume":"33","author":"V Staudt","year":"2010","unstructured":"Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N, et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity. 2010;33:192\u2013202.","journal-title":"Immunity"},{"key":"257_CR68","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.immuni.2016.04.013","volume":"44","author":"M Vaeth","year":"2016","unstructured":"Vaeth M, Eckstein M, Shaw PJ, Kozhaya L, Yang J, Berberich-Siebelt F, et al. Store-operated Ca2+ entry in follicular T cells controls Humoral immune responses and autoimmunity. Immunity. 2016;44:1350\u201364.","journal-title":"Immunity"},{"key":"257_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054267","volume":"8","author":"L Hu","year":"2013","unstructured":"Hu L, Wang T, Gocke AR, Nath A, Zhang H, Margolick JB, et al. Blockade of Kv1.3 potassium channels inhibits differentiation and Granzyme B secretion of human CD8+ T effector memory lymphocytes. PLoS One. 2013;8:e54267.","journal-title":"PLoS One"},{"key":"257_CR70","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri.2016.62","volume":"16","author":"J Grootjans","year":"2016","unstructured":"Grootjans J, Kaser A, Kaufman RJ, Blumberg RS. The unfolded protein response in immunity and inflammation. Nat Rev Immunol. 2016;16:469\u201384.","journal-title":"Nat Rev Immunol"},{"key":"257_CR71","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12974-017-0906-6","volume":"14","author":"S Rangaraju","year":"2017","unstructured":"Rangaraju S, Raza SA, Pennati A, Deng Q, Dammer EB, Duong D, et al. A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation. J Neuroinflammation. 2017;14:128.","journal-title":"J Neuroinflammation"},{"key":"257_CR72","doi-asserted-by":"crossref","unstructured":"Sim JH, Kim KS, Park H, Kim K-J, Lin H, Kim T-J, et al. Differentially Expressed Potassium Channels Are Associated with Function of Human Effector Memory CD8+ T Cells. Front Immunol. 2017;8:859.","DOI":"10.3389\/fimmu.2017.00859"},{"key":"257_CR73","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41467-017-00612-6","volume":"8","author":"S Klein-Hessling","year":"2017","unstructured":"Klein-Hessling S, Muhammad K, Klein M, Pusch T, Rudolf R, Fl\u00f6ter J, et al. NFATc1 controls the cytotoxicity of CD8+ T cells. Nat Commun. 2017;8:511.","journal-title":"Nat Commun"},{"key":"257_CR74","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0041-0101(95)00013-C","volume":"33","author":"O Casta\u00f1eda","year":"1995","unstructured":"Casta\u00f1eda O, Sotolongo V, Amor AM, St\u00f6cklin R, Anderson AJ, Harvey AL, et al. Characterization of a potassium channel toxin from the Caribbean Sea anemone Stichodactyla helianthus. Toxicon. 1995;33:603\u201313.","journal-title":"Toxicon"},{"key":"257_CR75","doi-asserted-by":"publisher","first-page":"e0180762","DOI":"10.1371\/journal.pone.0180762","volume":"12","author":"EJ Tarcha","year":"2017","unstructured":"Tarcha EJ, Olsen CM, Probst P, Peckham D, Mu\u00f1oz-El\u00edas EJ, Kruger JG, et al. Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial. PLoS One. 2017;12:e0180762.","journal-title":"PLoS One"},{"key":"257_CR76","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/md13010529","volume":"13","author":"M Pennington","year":"2015","unstructured":"Pennington M, Chang S, Chauhan S, Huq R, Tajhya R, Chhabra S, et al. Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK. Mar Drugs. 2015;13:529\u201342.","journal-title":"Mar Drugs"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-018-0257-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-018-0257-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-018-0257-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T06:06:50Z","timestamp":1751782010000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-018-0257-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["257"],"URL":"https:\/\/doi.org\/10.1186\/s12964-018-0257-7","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"1 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Vm24 peptide and its use are protected by an international patent application WO2008139243 A1 in the name of Universidad Nacional Aut\u00f3noma de Mexico (UNAM). The same subject was protected in several countries. In addition, a license was granted to a Mexican pharmaceutical company for commercial exploitation; however, the authors kept the right to continuing research in the field involving this peptide. The financing of this work came from the declared funding institutions only. No other possible conflicts of interest are involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"45"}}